SHARE
Neurotrophic Keratitis Market

Neurotrophic Keratitis - Global Market Outlook (2018-2027)

4.6 (65 reviews)
Published: March 2020 ID: SMRC19018
4.6 (65 reviews)
Published: March 2020 ID: SMRC19018

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Neurotrophic Keratitis Market is accounted for $60.56 million in 2018 and is expected to reach $279.06 million by 2027 growing at a CAGR of 18.5% during the forecast period. Rising reported cases and surge in investments in research and clinical study and product approvals are the major factors propelling the market growth. However, high cost of treatment is hampering the market growth.

Neurotrophic keratitis is anorphan disease which is mainly caused by the damage of the fifth cranial nerve from thetrigeminal nucleus to the nerve endings present in the eye corneal region.The treatment method is implemented as per the different stages of the disease.

Based on the treatment, the drugs segment is going to have a lucrative growth during the forecast period as artificial tears are prescribed for all the stages due to its ability to provide wetness and lubrication to the corneal surface and ensure cleanliness. By geography, North America is going to have a lucrative growth during the forecast period owing to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, and presence of key players.

Some of the key players profiled in the Neurotrophic Keratitis Market include Walgreens, ReGenTree, LLC, Novartis AG, Dompefarmaceutici S.p.A., CooperVision, Bayer AG, Bausch & Lomb Incorporated, Allergan, Plc., Abbott Laboratories, Inc. and Johnson & Johnson. 

Treatments Covered:
• Drugs
• Surgical Intervention

Stages Covered:
• Stage I
• Stage II
• Stage III  

Applications Covered:
• Clinic
• Hospital

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary        
          
2 Preface    
     
 2.1 Abstract        
 2.2 Stake Holders       
 2.3 Research Scope       
 2.4 Research Methodology      
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources       
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions      
          
3 Market Trend Analysis       
 3.1 Introduction       
 3.2 Drivers        
 3.3 Restraints        
 3.4 Opportunities       
 3.5 Threats        
 3.6 Application Analysis       
 3.7 Emerging Markets       
 3.8 Impact of Covid-19       
          
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes       
 4.4 Threat of new entrants      
 4.5 Competitive rivalry       
          
5 Global Neurotrophic Keratitis Market, By Treatment     
 5.1 Introduction       
 5.2 Drugs        
  5.2.1 Topical Antibiotics      
  5.2.2 RGN-259       
  5.2.3 Recombinant Human Nerve Growth Factors Eye Drop   
  5.2.4 Oral Antibiotics      
  5.2.5 Bandage Contact Lens      
  5.2.6 Artificial Tears      
 5.3 Surgical Intervention       
  5.3.1 Tarsorrhaphy      
  5.3.2 Amniotic Membrane Transplantation    
          
6 Global Neurotrophic Keratitis Market, By Stage     
 6.1 Introduction       
 6.2 Stage I         
 6.3 Stage II        
 6.4 Stage III        
          
7 Global Neurotrophic Keratitis Market, By Application     

 7.1 Introduction       
 7.2 Clinic        
 7.3 Hospital        
          
8 Global Neurotrophic Keratitis Market, By Geography     
 8.1 Introduction       
 8.2 North America       
  8.2.1 US       
  8.2.2 Canada       
  8.2.3 Mexico       
 8.3 Europe        
  8.3.1 Germany       
  8.3.2 UK       
  8.3.3 Italy       
  8.3.4 France       
  8.3.5 Spain        
  8.3.6 Rest of Europe      
 8.4 Asia Pacific       
  8.4.1 Japan       
  8.4.2 China       
  8.4.3 India       
  8.4.4 Australia       
  8.4.5 New Zealand      
  8.4.6 South Korea      
  8.4.7 Rest of Asia Pacific      
 8.5 South America       
  8.5.1 Argentina       
  8.5.2 Brazil       
  8.5.3 Chile       
  8.5.4 Rest of South America     
 8.6 Middle East & Africa       
  8.6.1 Saudi Arabia      
  8.6.2 UAE       
  8.6.3 Qatar       
  8.6.4 South Africa      
  8.6.5 Rest of Middle East & Africa     
          
9 Key Developments        
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 9.2 Acquisitions & Mergers      
 9.3 New Product Launch       
 9.4 Expansions       
 9.5 Other Key Strategies       
          
10 Company Profiling        
 10.1 Walgreens       
 10.2 ReGenTree LLC       
 10.3 Novartis AG       
 10.4 Dompe farmaceutici S.p.A.      
 10.5 CooperVision       
 10.6 Bayer AG        
 10.7 Bausch & Lomb Incorporated      
 10.8 Allergan Plc       
 10.9 Abbott Laboratories Inc      
 10.10 Johnson & Johnson     


List of Tables         
1 Global Neurotrophic Keratitis Market Outlook, By Region (2017-2027) ($MN)  
2 Global Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)  
3 Global Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)   
4 Global Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN) 
5 Global Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)  
6 Global Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
7 Global Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)  
8 Global Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN) 
9 Global Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)  
10 Global Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN) 
11 Global Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)  
12 Global Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
13 Global Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)   
14 Global Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)  
15 Global Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)  
16 Global Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)  
17 Global Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)  
18 Global Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)   
19 Global Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)  
20 North America Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)  
21 North America Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN) 
22 North America Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)  
23 North America Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN) 
24 North America Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)  
25 North America Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
26 North America Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN) 
27 North America Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
28 North America Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN) 
29 North America Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
30 North America Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN) 
31 North America Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
32 North America Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)  
33 North America Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)  
34 North America Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)  
35 North America Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)  
36 North America Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN) 
37 North America Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)  
38 North America Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)  
39 Europe Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)  
40 Europe Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)  
41 Europe Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)   
42 Europe Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN) 
43 Europe Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)  
44 Europe Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
45 Europe Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)  
46 Europe Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN) 
47 Europe Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)  
48 Europe Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN) 
49 Europe Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)  
50 Europe Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
51 Europe Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)   
52 Europe Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)  
53 Europe Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)  
54 Europe Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)  
55 Europe Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)  
56 Europe Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)   
57 Europe Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)  
58 Asia Pacific Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)  
59 Asia Pacific Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)  
60 Asia Pacific Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)  
61 Asia Pacific Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN) 
62 Asia Pacific Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)  
63 Asia Pacific Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
64 Asia Pacific Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN) 
65 Asia Pacific Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN) 
66 Asia Pacific Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN) 
67 Asia Pacific Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN) 
68 Asia Pacific Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN) 
69 Asia Pacific Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
70 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)  
71 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)  
72 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)  
73 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)  
74 Asia Pacific Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)  
75 Asia Pacific Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)  
76 Asia Pacific Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)  
77 South America Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)  
78 South America Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN) 
79 South America Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)  
80 South America Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN) 
81 South America Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)  
82 South America Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
83 South America Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN) 
84 South America Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
85 South America Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN) 
86 South America Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
87 South America Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN) 
88 South America Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
89 South America Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)  
90 South America Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)  
91 South America Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)  
92 South America Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)  
93 South America Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN) 
94 South America Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)  
95 South America Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)  
96 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN) 
97 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN) 
98 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN) 
99 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN)
100 Middle East & Africa Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN) 
101 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
102 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)
103 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
104 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN) 
105 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
106 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN) 
107 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
108 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN) 
109 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN) 
110 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN) 
111 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN) 
112 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN) 
113 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN) 
114 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials